Eppeltone Engineers share price lists with a stellar 90% premium at ₹243.20 on the NSE SME: Hit 5% upper circuit
Published 24 Jun 2025, 10:11 AM IST Eppeltone Engineers share price sees a stellar listing.
Eppeltone Engineers share price was listed with a stellar 90% premium at ₹ 243.20 on the NSE SME on Tuesday. The share gained further to hit 5% upper circuit post listing
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mint
12 hours ago
- Mint
Multibagger NSE SME stock rises 368% against the IPO price in two years
Shares of Basilic Fly Studio, listed on the NSE SME platform, have delivered massive multibagger returns since their debut, rising as much as 368 percent in just two years. From an issue price of rs 97, the stock now trades at ₹ 454.05, underscoring its strong wealth creation potential for early investors. While the company has multiplied investor wealth since its listing, its performance in the past year has been mixed. Over the last 12 months, the stock has corrected more than 20 percent. It hit a 52-week high of ₹ 657.60 in September 2024 and a 52-week low of ₹ 223.15 in February 2025. In terms of monthly trends, the stock has shown sharp swings. In August 2025 so far, it is up 5 percent, following a nearly 4 percent rise in July. Earlier, it declined 11 percent in June, but had staged strong rallies of 18 percent in May and 65 percent in April after a weak start to the year. The opening months of 2025 saw declines of 9.4 percent in January, 2 percent in February, and 18 percent in March. Basilic Fly Studio's IPO opened for subscription between September 1 and September 5, 2023, and was listed on the NSE SME exchange on September 11, 2023. The shares made a spectacular debut at ₹ 271, opening at a 179 percent premium over the issue price of ₹ 97. The IPO had garnered a strong investor response, oversubscribed 286.61 times. Against an issue size of 50.96 lakh shares, it received bids for 146.06 crore shares. The company had set a price band of ₹ 92–97 per share, with a total issue size of ₹ 66.35 crore (68,40,000 shares). This included a fresh issue of 62,40,000 shares aggregating to ₹ 60.53 crore and an offer for sale of 6,00,000 shares amounting to ₹ 5.83 crore. Earlier this week, Basilic Fly Studio announced a major order win worth ₹ 29.71 crore (GBP 2.5 million) from streaming giant Netflix. The engagement involves delivery of high-complexity VFX work for an upcoming premium project. This contract follows BFS's recent momentum in Q1 FY26, when it secured ₹ 150 crore worth of new orders from marquee clients such as Netflix, Disney, and HBO. The company highlighted that the project will leverage its global workforce of 800+ artists across India-led hubs in Chennai and Pune, alongside premium creative talent based in London, Paris, and Vancouver. Commenting on the development, Mr. Balakrishnan, Managing Director & CEO of Basilic Fly Studio Limited, said: 'This order reflects the trust we have built over the years by consistently delivering high-end, complex visual effects at scale, supported by our global footprint and integrated delivery model across India, UK, France, and Canada. As we move forward, our focus remains on accelerating innovation and expanding capacity in line with Vision 2026. With investments in AI-driven workflows, modular USD integration, and world-class talent, we are confident of sustaining our growth momentum and continuing to deliver creative excellence on some of the most ambitious projects in the global entertainment industry.' The new Netflix order aligns with BFS's Vision 2026 strategy, which focuses on expanding delivery capacity, building AI-driven production workflows, and scaling operations across India, North America, and Europe. The company's goal is to strengthen its global footprint and consolidate its position as a leading VFX studio catering to high-end international projects. Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.
Time of India
4 days ago
- Time of India
ANB Metal Cast shares to debut on NSE SME today. Check GMP ahead of debut
Live Events (You can now subscribe to our (You can now subscribe to our ETMarkets WhatsApp channel Shares of ANB Metal Cast will list on the NSE SME platform on Monday after concluding its Rs 49.92 crore IPO. Ahead of listing, the stock is trading with a GMP of 0%, indicating that the shares may debut around the issue price of Rs 156 per Rajkot-based aluminium extrusion manufacturer received a moderate response from investors, with the IPO subscribed 2.22 times retail category was subscribed 2.39 times, Qualified Institutional Buyers (QIBs) subscribed 1.04 times, while the Non-Institutional Investors (NII) category was subscribed 4.29 times. The company also raised Rs 14.02 crore from anchor investors ahead of the fresh issue of 32 lakh shares was aimed at funding the expansion of manufacturing facilities, working capital needs, and general corporate purposes. Post issue, the company's market capitalisation stands at Rs 184.62 in 2019, ANB Metal Cast manufactures a wide range of aluminium extrusion products such as motor bodies, solar profiles, railings, and sliding windows, catering to sectors including electronics, automotive, solar, and FY25, the company reported a revenue of Rs 162.64 crore, up 45% year-on-year, and a profit after tax (PAT) of Rs 10.25 crore, nearly doubling from Rs 5.34 crore in the company's strong financial growth, there are concerns over the sustainability of boosted profits. With a flat GMP, listing day movement will be closely watched to gauge investor sentiment.: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)
Time of India
4 days ago
- Time of India
Medistep Healthcare shares to list today. Here's what GMP suggests
Shares of Medistep Healthcare will debut on the NSE SME platform on Monday. The stock is commanding a strong grey market premium (GMP) of around 19%, suggesting healthy listing gains for investors. The Rs 16.10 crore IPO, which was open for subscription from August 8 to August 12, saw an overwhelming response, with an overall subscription of 382.14 times. The retail portion was subscribed to an exceptional 461.11 times, while Non-Institutional Investors (NII) subscribed 289.15 times. Priced at Rs 43 per share, the issue was entirely a fresh issue of 37.44 lakh shares. The company plans to utilise the proceeds for working capital, purchase of plant and machinery for expansion, and general corporate purposes. Incorporated in June 2023, Medistep Healthcare manufactures and trades a diverse range of products, including sanitary pads, nutraceuticals, pharmaceutical items, surgical supplies, and intimate care products. For FY25, the company reported revenue of Rs 49.66 crore and profit after tax of Rs 4.14 crore, reflecting growth of 27% and 25% respectively over FY24. Live Events While analysts note the company operates in a highly competitive and fragmented segment, the robust subscription figures and positive GMP signal strong investor appetite. All eyes will now be on the listing, where the stock is expected to debut at a healthy premium over the issue price. ( Disclaimer : Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)
